Showing results (31-40 of 48) with videos related to
Sort By:
Pageof 5
Breast Cancer Research and Treatment|February 28, 2021
Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registryPeter A Kaufman, Sara A Hurvitz, Joyce O'Shaughnessy, et al.Pediatric Clinics of North America|September 20, 2021
Impact of COVID-19 on Pediatric Immunocompromised PatientsJames A Connelly, Hey Chong, Adam J Esbenshade, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2008
Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100Bryan P Schneider, Molin Wang, Milan Radovich, et al.JCO Oncology Practice|February 3, 2021
Chemotherapy Remote Care Monitoring Program: Integration of SMS Text Patient-Reported Outcomes in the Electronic Health Record and Pharmacist Intervention for Chemotherapy-Induced Nausea and VomitingShannon Hough, Rachel McDevitt, Victoria R Nachar, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 27, 2021
Implementation and outcomes of a pharmacist-led collaborative drug therapy management program for oncology symptom managementMorgan J Homan, Justin H Reid, Victoria R Nachar, et al.Transplantation and Cellular Therapy|September 28, 2021
Impact of Pharmacogenetics on Intravenous Tacrolimus Exposure and Conversions to Oral TherapyAmy L Pasternak, Lauren A Marcath, Yajing Li, et al.Medrxiv : the Preprint Server for Health Sciences|June 27, 2020
A Digital Protein Microarray for COVID-19 Cytokine Storm MonitoringYujing Song, Yuxuan Ye, Shiuan-Haur Su, et al.Lab on a Chip|November 19, 2020
A digital protein microarray for COVID-19 cytokine storm monitoringYujing Song, Yuxuan Ye, Shiuan-Haur Su, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast CancerCynthia X Ma, Jingqin Luo, Rachel A Freedman, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 4, 2014
Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomesLawrence Chang, David Frame, Thomas Braun, et al.Pageof 5